Abstract
Ayurveda, An Indian system of medicine has described several drugs from indigenous plant sources for use in the treatment of bronchial asthma and allergic disorders. Traditionally Fagonia schweinfurthii Hadidi (Family- Zygophylaceae) is used for allergies and other skin diseases. The current study evaluates the anti-histaminic activity of aqueous extract of F. schweinfurthii Hadidi and then anti-histaminic formulation (syrup) was prepared and evaluated for various parameters. Plant Fagonia schweinfurthii Hadidi was collected from local area. Aqueous extract was obtained by extraction of moderately coarse powder of F. schweinfurthii Hadidi was carried out by decoction method with water and dried. Anti-histaminic activity of plant extract was evaluated by using Guinea pig ileum and for the comparison of anti-histaminic activity ceterizine (10 mg) was used as model drug. In the present study it was found that aqueous extract of F. schweinfurthii Hadidi showed significant anti-histaminic activity. The outcomes of study showed that 16% and 18.8% inhibition in maximum response produced by histamine was observed for plant extract (1000 μg/ml) and standard drug (50 μg/ml) respectively when 5 μg/ml dose of histamine was used. From this study 2 g dose was selected for the preparation of syrup. The results indicate that aqueous extract of F. schweinfurthii Hadidi has significant anti-histaminic activity and syrup which contains 2 g of extract has similar anti-histaminic activity to marketed preparation.
Keywords: Aqueous extract, concentration response curve, fagonia.
The Natural Products Journal
Title:Screening of Anti-Histaminic Activity of Fagonia Schweinfurthii Hadidi in Guinea Pig Ileum and Formulate Anti-Histaminic Syrup
Volume: 5 Issue: 3
Author(s): Dinesh Puri, Anil Bhandari and Praveen Kumar Gaur
Affiliation:
Keywords: Aqueous extract, concentration response curve, fagonia.
Abstract: Ayurveda, An Indian system of medicine has described several drugs from indigenous plant sources for use in the treatment of bronchial asthma and allergic disorders. Traditionally Fagonia schweinfurthii Hadidi (Family- Zygophylaceae) is used for allergies and other skin diseases. The current study evaluates the anti-histaminic activity of aqueous extract of F. schweinfurthii Hadidi and then anti-histaminic formulation (syrup) was prepared and evaluated for various parameters. Plant Fagonia schweinfurthii Hadidi was collected from local area. Aqueous extract was obtained by extraction of moderately coarse powder of F. schweinfurthii Hadidi was carried out by decoction method with water and dried. Anti-histaminic activity of plant extract was evaluated by using Guinea pig ileum and for the comparison of anti-histaminic activity ceterizine (10 mg) was used as model drug. In the present study it was found that aqueous extract of F. schweinfurthii Hadidi showed significant anti-histaminic activity. The outcomes of study showed that 16% and 18.8% inhibition in maximum response produced by histamine was observed for plant extract (1000 μg/ml) and standard drug (50 μg/ml) respectively when 5 μg/ml dose of histamine was used. From this study 2 g dose was selected for the preparation of syrup. The results indicate that aqueous extract of F. schweinfurthii Hadidi has significant anti-histaminic activity and syrup which contains 2 g of extract has similar anti-histaminic activity to marketed preparation.
Export Options
About this article
Cite this article as:
Puri Dinesh, Bhandari Anil and Kumar Gaur Praveen, Screening of Anti-Histaminic Activity of Fagonia Schweinfurthii Hadidi in Guinea Pig Ileum and Formulate Anti-Histaminic Syrup, The Natural Products Journal 2015; 5 (3) . https://dx.doi.org/10.2174/2210315505666150707183856
DOI https://dx.doi.org/10.2174/2210315505666150707183856 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nasal Polyposis: From Pathogenesis to Treatment, An Update
Inflammation & Allergy - Drug Targets (Discontinued) Editorial [Hot Topic:Toward Translational Research on VIP AND PACAP (Executive Editor: A. Arimura)]
Current Pharmaceutical Design Pharmacokinetics of Topical Ocular Drug Delivery: Potential Uses for the Treatment of Diseases of the Posterior Segment and Beyond
Current Drug Metabolism Allergy in Pediatric Age: An Update
Current Pediatric Reviews New Applications for Sublingual Immunotherapy in Allergy
Recent Patents on Inflammation & Allergy Drug Discovery Synthetic 2-Methoxyestradiol Derivatives: Structure-Activity Relationships
Current Medicinal Chemistry Mapracorat, a Novel Non-Steroidal Selective Glucocorticoid Receptor Agonist for the Treatment of Allergic Conjunctivitis
Inflammation & Allergy - Drug Targets (Discontinued) Suppression of Inflammatory and Allergic Responses by Pharmacologically Potent Fungus Ganoderma lucidum
Recent Patents on Inflammation & Allergy Drug Discovery Hypersensitivity to Antineoplastic Agents
Current Pharmaceutical Design The Re-Emergence of Aerosol Gene Delivery: A Viable Approach to Lung Cancer Therapy
Current Cancer Drug Targets Development Steps of Pharmacokinetics: A Perspective on Bioanalytical Methods and Bioequivalence
Current Clinical Pharmacology Subject Index
Current Drug Targets - Inflammation & Allergy Cytochrome P450 Drug Metabolizing Enzymes in Roma Population Samples: Systematic Review of the Literature
Current Medicinal Chemistry Misoprostol Reverse Hippocampal Neuron Cyclooxygenase-2 Downstream Signaling Imbalance in Aluminum-Overload Rats
Current Alzheimer Research Vaccine Adjuvants: Key Tools for Innovative Vaccine Design
Current Topics in Medicinal Chemistry Development and Validation of a Sensitive LC-MS/MS Method for Determination of Betamethasone in Human Plasma. Application to a Pharmacokinetic Study of Healthy Mexican Subjects
Current Pharmaceutical Analysis Why are People with “Poor Lung Function” At Increased Atherothrombotic Risk?A Critical Review with Potential Therapeutic Indications
Current Vascular Pharmacology Hyperglycemia and Diabetes Induced by Glucocorticoids in Nondiabetic and Diabetic Patients: Revision of Literature and Personal Considerations
Current Pharmaceutical Biotechnology Lipoic Acid: A Novel Therapeutic Approach for Multiple Sclerosis and Other Chronic Inflammatory Diseases of the CNS
Endocrine, Metabolic & Immune Disorders - Drug Targets Electronic Noses in Medical Diagnostics
Current Medicinal Chemistry